Clinical Trials Browser

OTHER × Leukemia, B-Cell × Clear all

NCT01683279 2026-06-05

A Pediatric Trial of Genetically Modified Autologous T Cells Directed Against CD19 for Relapsed CD19+ Acute Lymphoblastic Leukemia

Phase 1 Active not recruiting

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07624799 2026-06-03

PACIFIC

Phase 2 Not yet recruiting

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT07511426 2026-05-28

U96-CAR-T-Cells For R/R B-ALL

Phase 1 Not yet recruiting

LymphoidOther hematologic neoplasm

Lymphoma, Recurrence, Leukemia, B-Cell

NCT03573700 2026-05-20

Evaluation of CD19-Specific CAR Engineered Autologous T-Cells for Treatment of Relapsed/Refractory CD19+ Acute Lymphoblastic Leukemia

Phase 1/2 Active not recruiting

24 enrolled 9 charts

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphoid, Recurrence, Leukemia, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02787369 2026-05-19

ACY-1215 in Combination With BCR Pathway Inhibitors in Relapsed CLL

Phase 1 Active not recruiting

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, B-Cell

NCT03774654 2026-05-18

CD19.CAR Allogeneic NKT for Patients With Relapsed or Refractory B-Cell Malignancies (ANCHOR)

Phase 1 Active not recruiting

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Leukemia, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04608318 2026-04-30

CLL17

Phase 3 Active not recruiting

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT04016129 2026-04-23

CAR-T Immunotherapy Targeting CD19- ALL

Phase 1/2 Recruiting

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT06208735 2026-04-03

CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies

Phase 1 Recruiting

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Non-Hodgkin, Leukemia, B-Cell, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT07487428 2026-03-23

CLL-IMPACT

Phase NA Recruiting

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT07422337 2026-02-25

BOOSTER

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Neoplasms, Leukemia, B-Cell

NCT07337967 2026-01-13

Reticulocyte Parameters as Early Indicators of Bone Marrow Erythropoietic Activity in Chronic B Lymphoproliferative Neoplasms

Not yet recruiting

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT07166549 2025-12-24

BaseCAR-01

Phase 1 Not yet recruiting

LymphoidOther hematologic neoplasm

Cytokine Release Syndrome, Lymphoma, Non-Hodgkin, Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06345027 2025-12-16

CASEY

Phase 1 Not yet recruiting

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, B-Cell, Leukemia, T-Cell, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT02650414 2025-12-12

CD22 Redirected Autologous T Cells for ALL

Phase 1 Active not recruiting

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Lymphoma, B-Cell

NCT03766763 2025-11-26

Preemptive Therapy for High Risk Chronic Lymphoid Leukemia Stage A

Phase 2 Active not recruiting

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT02050347 2025-11-14

CARPASCIO

Phase 1 Active not recruiting

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Non-Hodgkin, Leukemia, B-Cell

NCT05010564 2025-11-13

TRICAR-ALL

Phase 1 Recruiting

LymphoidOther hematologic neoplasm

Recurrence, Leukemia, B-Cell

NCT03050190 2025-09-08

A Phase I/II Multiple Center Trial of 4SCAR19 Cells in the Treatment of Relapsed and Refractory B Cell Malignancies

Phase 1/2 Recruiting

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT03125577 2025-09-08

Combination CAR-T Cell Therapy Targeting Hematological Malignancies

Phase 1/2 Recruiting

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT05779930 2025-08-15

Safety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHL

Phase EARLY_PHASE1 Not yet recruiting

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07113132 2025-08-08

Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia

Not yet recruiting

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06812715 2025-08-06

PIPOZA

Phase 2 Recruiting

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell

NCT04515238 2025-06-10

CLL2-BZAG

Phase 2 Active not recruiting

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT04883749 2025-06-08

CLL-Frail

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT03804372 2025-02-27

CLL1818

Phase 2 Terminated

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT06834529 2025-02-19

CAR2219 CAR-T Cells for the Treatment of R/R B Cell Leukemia and Lymphoma

Phase 1/2 Recruiting

LymphoidOther hematologic neoplasm

Lymphoma, Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell

NCT06821880 2025-02-12

PRO-SID

LymphoidOther hematologic neoplasmPlasma cell

Infections, Multiple Myeloma, Leukemia, B-Cell

NCT06762431 2025-01-07

VTB-CLL002

Phase 1/2 Enrolling by invitation

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell

NCT03787264 2024-12-30

CLL2-BAAG

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT04605666 2024-08-20

CD19-CAR-T2 Cells for CD19 Positive B Cell Malignancies

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Lymphoma, B-Cell

NCT01597219 2024-05-03

UK-Haplo

Phase 2 Completed

LymphoidMyeloidOther hematologic neoplasm

Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06355739 2024-04-09

CD19-targeted CAR T Cell Autotransfusion for the Treatment of Recurrent/Refractory B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Children With CD19+

Phase NA Recruiting

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

NCT03098355 2024-03-18

Interleukin-2 Following 4SCAR19/22 T Cells Targeting Refractory and/or Recurrent B Cell Malignancies

Phase 1/2 Withdrawn

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Lymphoma, B-Cell

NCT04090268 2024-01-02

SportTherapy

Phase NA Unknown

LymphoidOther hematologic neoplasm

Adrenoleukodystrophy, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Motor Activity, Neoplasms, Sickle Cell Trait, Leukemia, B-Cell, Leukemia, T-Cell, Leukemia, Myeloid, Acute, beta-Thalassemia

NCT05082519 2023-10-26

IDEAL2

Phase 2 Recruiting

LymphoidOtherOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Obesity, Leukemia, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Pediatric Obesity

NCT05350826 2023-09-21

THEMIS

Phase NA Unknown

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT05932173 2023-07-11

A Study of Novel Anti-CD19 CAR-T in Patients With r/r B-Cell Malignancies

Phase 1/2 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Leukemia, B-Cell, Lymphoma, B-Cell

NCT05095155 2023-03-14

Study of the Prognostic Role of Gene Polymorphism in the Development of B-cell Leukemias and Lymphomas in Children of Kazakh Nationality

LymphoidOther hematologic neoplasm

Lymphoma, Leukemia, B-Cell

NCT03899337 2023-01-09

STELLAR

Phase 2 Recruiting

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Leukemia, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT05570188 2022-11-30

Anti-CD19 Universal CAR-NK Cells Therapy Combined With HSCT for B Cell Hematologic Malignancies

Phase 1/2 Withdrawn

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Lymphoma, B-Cell

NCT03852407 2022-10-12

HLA

Phase 2 Recruiting

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Graft vs Host Disease, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, B-Cell, Hematologic Neoplasms

NCT05099068 2022-07-05

PLANET

Phase NA Unknown

CNSLymphoidOther hematologic neoplasm

Glioblastoma, Leukemia, B-Cell

NCT03564470 2022-07-01

Precision Diagnosis Directing HDACi and TKI Target Therapy for Adult Ph-like ALL

Phase 2/3 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04260945 2022-03-08

CD19/CD20 Dual-CAR-T in B-cell Leukemia Patients

Phase 1 Completed

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT03068416 2021-10-20

CD19-targeting, 3rd Generation CAR T Cells for Refractory B Cells Malignancy

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Lymphoma, B-Cell

NCT02933320 2021-07-08

BI-1206 and an Anti-CD20 Antibody in Patients With CD32b Positive B-cell Lymphoma or Leukaemia

Phase 1/2 Completed

14 enrolled 17 charts

LymphoidOther hematologic neoplasm

Waldenstrom Macroglobulinemia, Leukemia, B-Cell, Lymphoma, B-Cell

NCT03605589 2021-04-01

Pembro + Blina Combination in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Leukemia or Lymphoma

Phase 1 Withdrawn

LymphoidOther hematologic neoplasm

Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell

NCT04747093 2021-02-10

Induced-T Cell Like NK Cells for B Cell Malignancies

Phase 1/2 Unknown

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, B-Cell, Lymphoma, B-Cell

NCT03294980 2021-01-28

OFICE

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell